-Purpose: To evaluate early visual, refractive and aberrometric outcomes after wave front-guided LASIK for the correction of low to moderate myopia and myopic astigmat is musing the excimer laser platform Advanced Cus...-Purpose: To evaluate early visual, refractive and aberrometric outcomes after wave front-guided LASIK for the correction of low to moderate myopia and myopic astigmat is musing the excimer laser platform Advanced Custom Vue. Methods: A prospective, non-comparative study in 100 myopic eyes of 50 patients evaluating LASIK results over a period of 3 months. Main outcome variables included visual acuity, refraction, total higher-order aberrations (HOAs), spherical aberration (SA) and coma-like aberration. The surgery was performed using the VISX STAR S4 (Johnson and Johnson Vision) excimer laser and a wave front-guided ablation designed according to the iDesign aberrometer data (Johnson and Johnson Vision). Results: Mean preoperative sphere decreased from -4.07 ± 1.78 D to 0.32 ± 0.30 D at 3 months after surgery. Mean preoperative cylinder was reduced from -1.09 ± 0.88 D to -0.26 ± 0.28 D after the complete follow-up. Postoperative uncorrected distance visual acuity (UDVA) was 0.00 logMAR (20/20) or better in 100% of eyes, and 65.3% of eyes reached an UDVA of -0.20 logMAR (20/12.5) or better (p < 0.05). For a 6-mm pupil, the root mean square (RMS) for total ocular HOAs increased with surgery by 0.03 μm (p = 0.050), whereas the coma-like RMS increased by 0.05 μm (p < 0.001). The change in spherical aberration was +0.08 μm (p < 0.001). Conclusion: Wavefront-guided LASIK using the new generation excimer laser platform Advanced Custom Vue is safe and effective for treating myopia and myopic astigmatism, minimizing the postoperative level of HOAs.展开更多
文摘-Purpose: To evaluate early visual, refractive and aberrometric outcomes after wave front-guided LASIK for the correction of low to moderate myopia and myopic astigmat is musing the excimer laser platform Advanced Custom Vue. Methods: A prospective, non-comparative study in 100 myopic eyes of 50 patients evaluating LASIK results over a period of 3 months. Main outcome variables included visual acuity, refraction, total higher-order aberrations (HOAs), spherical aberration (SA) and coma-like aberration. The surgery was performed using the VISX STAR S4 (Johnson and Johnson Vision) excimer laser and a wave front-guided ablation designed according to the iDesign aberrometer data (Johnson and Johnson Vision). Results: Mean preoperative sphere decreased from -4.07 ± 1.78 D to 0.32 ± 0.30 D at 3 months after surgery. Mean preoperative cylinder was reduced from -1.09 ± 0.88 D to -0.26 ± 0.28 D after the complete follow-up. Postoperative uncorrected distance visual acuity (UDVA) was 0.00 logMAR (20/20) or better in 100% of eyes, and 65.3% of eyes reached an UDVA of -0.20 logMAR (20/12.5) or better (p < 0.05). For a 6-mm pupil, the root mean square (RMS) for total ocular HOAs increased with surgery by 0.03 μm (p = 0.050), whereas the coma-like RMS increased by 0.05 μm (p < 0.001). The change in spherical aberration was +0.08 μm (p < 0.001). Conclusion: Wavefront-guided LASIK using the new generation excimer laser platform Advanced Custom Vue is safe and effective for treating myopia and myopic astigmatism, minimizing the postoperative level of HOAs.
